Mark Kaddumukasa Selected Research

Mark Kaddumukasa Research Topics

Disease

8	Malaria 11/2021 - 09/2005
4	Epilepsy (Aura) 01/2021 - 03/2016
3	Fever (Fevers) 01/2020 - 02/2012
3	Hypertension (High Blood Pressure) 12/2017 - 09/2016
2	Diabetes Mellitus 01/2022 - 06/2017
2	Stroke (Strokes) 01/2021 - 12/2017
2	COVID-19 01/2021 - 01/2020
2	Seizures (Absence Seizure) 03/2016 - 11/2013
2	Infections 01/2015 - 11/2013
1	Arthralgia (Joint Pain) 12/2021
1	Knee Osteoarthritis 12/2021
1	Pain (Aches) 12/2021
1	Osteoarthritis 12/2021
1	Latent Tuberculosis 06/2021
1	Neuroinflammatory Diseases 01/2020
1	Rheumatoid Arthritis 01/2020
1	Neuroleptic Malignant Syndrome 01/2020
1	Periodontitis 01/2020
1	Hypertensive Crisis 03/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 06/2017
1	Acute malaria 01/2017
1	Demyelinating Diseases (Demyelinating Disease) 07/2013
1	Quadriplegia (Spastic Quadriplegia) 07/2013
1	Urinary Incontinence 07/2013

Drug/Important Bio-Agent (IBA)

5	VaccinesIBA 01/2021 - 01/2015
5	Pharmaceutical PreparationsIBA 01/2021 - 09/2005
2	aluminum sulfate (alum)IBA 01/2021 - 01/2016
2	Malaria VaccinesIBA 01/2021 - 11/2014
2	Rabies Vaccines (Rabies Vaccine)FDA Link 01/2021 - 01/2016
2	Biological ProductsIBA 01/2021 - 01/2021
2	AntibodiesIBA 01/2020 - 01/2015
2	SaltsIBA 12/2017 - 09/2016
2	Immunoglobulin G (IgG)IBA 01/2016 - 01/2015
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Vitamin D FDA LinkGeneric 12/2021
1	Glycoproteins (Glycoprotein)IBA 11/2021
1	OsteopontinIBA 11/2021
1	Proteins (Proteins, Gene)FDA Link 11/2021
1	GoldIBA 06/2021
1	COVID-19 VaccinesIBA 01/2021
1	Biological FactorsIBA 01/2021
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021
1	clopenthixol acetate esterIBA 01/2020
1	Antipsychotic Agents (Antipsychotics)IBA 01/2020
1	Antihypertensive Agents (Antihypertensives)IBA 03/2019
1	LipidsIBA 12/2017
1	potashIBA 12/2017
1	Blood Glucose (Blood Sugar)IBA 06/2017
1	NAD (NADH)IBA 06/2017
1	hemoglobin AAIBA 01/2017
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2017
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2017
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2017
1	Genetic Markers (Genetic Marker)IBA 01/2017
1	hemoglobin ASIBA 01/2017
1	SodiumIBA 09/2016
1	Aluminum Hydroxide (Algeldrate)FDA Link 01/2016
1	Immunoglobulins (Immunoglobulin)IBA 01/2015
1	Peptides (Polypeptides)IBA 01/2015
1	SteroidsIBA 07/2013
1	Azathioprine (Imuran)FDA LinkGeneric 07/2013
1	artemisinin (artemisinine)IBA 02/2012
1	ArtemisininsIBA 02/2012
1	Antimalarials (Antimalarial Agents)IBA 02/2012
1	pyrimethamine drug combination fanasil (Fansidar)FDA Link 02/2012

Therapy/Procedure

2	Therapeutics 11/2013 - 02/2012
1	Oral Hygiene (Dental Hygiene) 01/2020
1	Intramuscular Injections 01/2020
1	Artificial Respiration (Mechanical Ventilation) 01/2020
1	Injections 01/2016
1	Duration of Therapy 11/2013